NZ's BLIS Technologies rises most in 7 years on partnership with Swedish co

BLIS Technologies

07/07/2021 24:17

** Shares of biotech firm BLIS Technologies  BLT.NZ  climb
as much as 42.1% to NZ$0.08, their biggest intraday pct gain
since Aug 25, 2014
    ** BLT signs strategic partnership with Sweden-based Probi
AB  PROB.ST , a company that focuses on researching,
manufacturing and delivering probiotics for supplements and
functional food  urn:newsml:reuters.com:*:nNZW9LbW9Q
    ** BLT grants Probi rights to manufacture and sell BLIS K12
and BLIS M18, which are specific strains of bacteria that
actively crowd out bad bacteria in the human mouth
    ** Says both cos will collaborate in R&D to leverage joint
strengths in probiotic innovation
    ** Probi has invested about NZ$9 mln ($6.30 mln) in newly
issued BLT shares, corresponding to 13% ownership in BLT
    ** BLT hits highest since Feb 10
    ** More than 6.5 mln BLT shares change hands vs 30-day
average volume of ~652,000 shares
    ** Stock down 30.5% this year, as of last close
    
  


($1 = 1.4276 New Zealand dollars)

 (Reporting by Harish Sridharan in Bengaluru)
 ((harish.sridharan@thomsonreuters.com))